盐酸坦索罗辛治疗前列腺增生症的系统回顾及更新荟萃分析(4)
Meta-analysisPrimary comparison was made between symptom score, MFR, QOL and AEs for tamsulosin in the treatment of BPH. In order to further detect any differences in symptom score, Qmax/MFR, QOL and AEs based on the different treatment dosages, subgroup analysis based on the treatment dosages (0.2mg/0.4mg/0.8mg) was performed. The results of meta-analysis for each indicator are listed below.
Efficacy outcomes
Improvement on symptom score: one of ten studies did not report symptom score while the remaining articles described the differences before and after treatment ......
您现在查看是摘要页,全文长 3029 字符。